Table 6.
Unadjusted and adjusted Hazard Ratios for all-cause mortality in partner participants
Unadjusted Cox Model | Adjusted Cox Model1 | Multivariable Cox Model2 | |||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95% CI3 | p-value4 | aHR | 95% CI3 | p-value4 | aHR | 95% CI3 | p-value4 | |
Age | 1.04 | 0.97, 1.11 | 0.264 | 1.04 | 0.97, 1.12 | 0.211 | 1.04 | 0.97, 1.11 | 0.230 |
Gender | 0.801 | 0.409 | 0.522 | ||||||
Female | REF | REF | REF | ||||||
Male | 1.20 | 0.34, 7.58 | 1.80 | 0.50,11.49 | 1.58 | 0.44,10.13 | |||
Study site | 0.173 | 0.130 | 0.061 | ||||||
Indonesia | REF | REF | REF | ||||||
Ukraine | 1.78 | 0.57, 7.81 | 1.57 | 0.49, 7.02 | 2.02 | 0.63, 8.97 | |||
Vietnam | 0.66 | 0.15, 3.35 | 0.52 | 0.11, 2.70 | 0.56 | 0.12, 2.90 | |||
Study arm | 0.026 | 0.023 | 0.029 | ||||||
SOC | REF | REF | REF | ||||||
Intervention | 0.17 | 0.01, 0.84 | 0.17 | 0.01, 0.82 | 0.18 | 0.01, 0.86 | |||
Alcohol use in the past 3 months | 0.225 | 0.393 | |||||||
Non Hazardous alcohol use | REF | REF | |||||||
Hazardous alcohol use | 1.76 | 0.70, 4.36 | 1.51 | 0.58, 3.94 | |||||
Injecting opioids in the past 3 months5 | 0.071 | 0.103 | |||||||
No | REF | REF | |||||||
Yes | 3.64 | 0.48,466.7 | 3.06 | 0.37,399.1 | |||||
Injecting stimulants in the past 3 months | 0.790 | 0.239 | |||||||
No | REF | REF | |||||||
Yes | 0.85 | 0.20, 2.55 | 0.48 | 0.11, 1.58 | |||||
Injecting other drugs in the past 3 months | 0.294 | 0.933 | |||||||
No | REF | REF | |||||||
Yes | 1.71 | 0.60, 4.34 | 0.95 | 0.30, 3.00 | |||||
No injecting drug use in the past 3 months5 | 0.090 | 0.149 | |||||||
No | REF | REF | |||||||
Yes | 0.32 | 0.00, 2.48 | 0.41 | 0.00, 3.73 | |||||
Injecting polydrug use in the past 3 months | 0.320 | 0.635 | |||||||
No | REF | REF | |||||||
Yes | 1.60 | 0.62, 3.95 | 0.75 | 0.24, 2.61 | |||||
# of days of injecting drugs use in the past month | 1.03 | 0.99, 1.08 | 0.134 | 1.03 | 0.98, 1.08 | 0.277 | |||
Non-injecting opioids use in the past 3 months | 0.754 | 0.989 | |||||||
No | REF | REF | |||||||
Yes | 0.74 | 0.04, 3.57 | 0.99 | 0.05, 5.18 | |||||
Non-injecting stimulants use in the past 3 months | 0.700 | 0.753 | |||||||
No | REF | REF | |||||||
Yes | 0.82 | 0.26, 2.15 | 0.84 | 0.25, 2.37 | |||||
Non-injecting other drug use in the past 3 months | 0.857 | 0.884 | |||||||
No | REF | REF | |||||||
Yes | 1.09 | 0.44, 2.81 | 0.93 | 0.37, 2.49 | |||||
No non-injecting drug use in the past 3 months | 0.965 | 0.799 | |||||||
No | REF | REF | |||||||
Yes | 1.02 | 0.36, 2.59 | 1.14 | 0.39, 2.98 | |||||
Non-injecting polydrug use in the past 3 months | 0.822 | 0.916 | |||||||
No | REF | REF | |||||||
Yes | 0.88 | 0.25, 2.43 | 0.94 | 0.25, 2.76 | |||||
OAT status | 0.046 | 0.036 | 0.081 | ||||||
ever used | REF | REF | REF | ||||||
OAT naïve | 2.68 | 1.02, 8.32 | 2.81 | 1.06, 8.78 | 2.38 | 0.90, 7.40 |
1 Age, gender, site, arm was adjusted for in the Adjusted Cox Models
2 Those significant in the adjusted cox models were selected in this model with conservative cutoff point of 0.1. adjusting for age, gender, site, arm, only those with p-value < 0.1 will be left in the final model
3 Profile likelihood 95% confidence interval
4 Logrank type3 p-value
5 Firth's method with Breslow for ties was used when there was a zero event count. Elsewhere Efron's method was used for ties